PDGFRB and gastric cancer: PDGFRB that encodes platelet-derived growth factor receptor-β is overexpressed in gastric cancer tissue and associated with poor 5-years overall survival in patients with stage II/III gastric cancer receiving adjuvant chemotherapy with S-1, serving as an independent predictor of survival (Higuchi et al., 2017).